Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Lidocaine recalled?

Yes — there is an active recall. 61 ongoing FDA recalls mention Lidocaine (366 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Lidocaine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Lidocaine recalls on record

none so far in 2026; 366 on record, newest first
Class III · Low risk

Lidocaine Patch 5%

Labeling: Typographical error on the upper left-hand side of the box and individual patch label that has the incorrect dosage form stating, each tablet contains instead of each adhesive patch contains.

Ongoing Labeling / mix-up Bryant Ranch Prepack, Inc. D-0556-2023
Class I · High risk

Easy Care first aid Burn Cream

Microbial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.

Terminated Microbial contamination GFA Production Xiamen Co. Ltd. D-0244-2023
Class II · Moderate risk

Lidocaine-Pf- 5%

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Terminated Sterility / contamination Pharmacy Innovations D-0218-2023
Class II · Moderate risk

Epi-Caine

CGMP Deviations: Raw material recalled by repackager, due to discoloration.

Terminated Failed specification Pine Pharmaceuticals, LLC NDC 69194-0948-1 D-0130-2023
Class II · Moderate risk

Lidocaine Hydrochloride Jelly USP

cGMP Deviations: Turbidity discovered in Artificial Tears Ointment during sterility testing. Scope expanded to include other lots and products which potentially share the same root cause.

Terminated Sterility / contamination Akorn, Inc. NDC 17478-711-31 D-1495-2022
Class II · Moderate risk

Lidocaine 2%

Lack of assurance of sterility.

Completed Sterility / contamination Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0097-30 D-0930-2022
Class II · Moderate risk

Lidocaine Prilocaine Cream USP

CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.

Ongoing Stability / shelf life McKesson Corporation dba McKesson Drug Company NDC 63739-054-66 D-0849-2022
Class II · Moderate risk

Lidocaine Hydrochloride Topical Solution USP 4%

CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.

Ongoing Stability / shelf life McKesson Corporation dba McKesson Drug Company NDC 63739-977-64 D-0848-2022